GLP-1 Companion Supplements, Joint Recommendation From Four Medical Societies
As the number of people taking GLP-1 receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) surges worldwide, a new challenge is emerging: weight drops, but nutritional status deteriorates. The American College of Lifestyle Medicine (ACLM), the American Society for Nutrition (ASN), the Obesity Medicine Association (OMA), and The Obesity Society have jointly published a companion nutrition supplementation guide specifically for GLP-1 users.
When Appetite Drops, Nutrients Drop Too
The core mechanism of GLP-1 agonists is appetite suppression. Gastric motility slows, satiety lasts longer, and food intake decreases substantially. The problem is that essential nutrient intake declines alongside calories.
The key deficiency nutrients flagged in the guidance are vitamin B12, iron, magnesium, and vitamin D. Symptoms include fatigue, brain fog, hair thinning, and declining muscle strength. Because GLP-1 reduces stomach acid secretion, acid-dependent nutrients like B12 and iron are particularly affected.
The Recommended Companion Supplement Stack
A multivitamin serves as the foundation, covering broad micronutrient gaps when food intake has dropped. On top of this, the guidance recommends adding vitamin B12 (sublingual or methylcobalamin form), iron, magnesium, and vitamin D at 2,000IU (50ug) separately.
Muscle preservation is the second pillar. Up to 40% of weight lost on GLP-1 medications may come from muscle. The protein target is 1.2~1.6g per kilogram of body weight. Creatine at 3~5g per day and HMB (beta-hydroxy beta-methylbutyrate) at 3g per day are recommended to promote muscle protein synthesis and inhibit breakdown.
Dietary fiber (25~30g per day) and probiotics are also included for gut health. Constipation is a common side effect of GLP-1’s slowed gastric motility, making adequate fiber and hydration essential.
Same Rules Apply to Next-Generation GLP-1 Agents
Orforglipron (oral formulation) and retatrutide (triple agonist), the next wave of GLP-1 agents, share the same appetite suppression mechanism. Dual and triple agonists may actually accelerate weight loss, potentially increasing the risk of nutrient deficiency and muscle loss. The guidance explicitly states that the same supplementation protocol should apply to next-generation agents.
Check What You Are Already Taking First
Before adding supplements to a GLP-1 regimen, review the ingredients and doses in your current multivitamin or existing supplements. If your multivitamin already contains 1,000ug of B12 and 200mg of magnesium, additional supplementation may be unnecessary or the dose should be adjusted. A blood test is the most accurate way to confirm actual deficiency. Iron in particular can accumulate in the liver with excess supplementation, so checking your ferritin level before deciding on iron supplementation is the standard we recommend.
Frequently Asked Questions
What supplements are essential while taking GLP-1 medications? According to the joint recommendation from four medical societies, the baseline includes a multivitamin, vitamin B12, iron, magnesium, and vitamin D. For muscle loss prevention, protein (1.2~1.6g per kg body weight), creatine (3~5g daily), and HMB (3g daily) are also recommended.
What are the symptoms of B12 deficiency during GLP-1 use? Fatigue, brain fog (difficulty concentrating), tingling in hands and feet, and dizziness are common symptoms. GLP-1 reduces stomach acid secretion and slows gastric motility, both of which impair B12 absorption. Sublingual or methylcobalamin forms of B12 offer higher absorption.
Why is dietary fiber important for GLP-1 users? GLP-1 slows gastric motility, making constipation a common side effect. Daily intake of 25~30g of dietary fiber along with adequate hydration is needed to maintain gut health. Adding a probiotic can also help maintain gut microbial diversity.
Do next-generation GLP-1 agents (orforglipron, retatrutide) require the same supplementation? Yes. Next-generation GLP-1 agents share the same appetite suppression mechanism, so reduced nutrient intake remains an issue. Dual and triple agonists can produce faster weight loss, which may increase the risk of muscle loss and nutrient deficiency.